methotrex treatment unruptur ectop pregnanc report case ongo clinic trial patient unruptur ectop pregnanc cm dimens outpati protocol methotrex citrovorum factor chemotherapi methotrex citrovorum day hcg titer consecut day patient age year gravid pariti twenty-thre patient previou ectop pregnanc patient methotrexate/citrovorum primari therapi persist hcg titer conserv surgic procedur tubal pregnanc patient no laparoscopi wherea patient no nonlaparoscop algorithm patient medic therapi surgeri ectop pregnanc cardiac activ intercours case specif identifi risk factor ectop pregnanc cardiac activ patient methotrexate-rel side effect fourth dose none treatment side effect hysterosalpingogram patient tubal patenc involv side date pregnanc group intrauterin recurr ectop pregnanc methotrexate/citrovorum safe effect reproduct perform primari therapi unruptur ectop pregnanc treatment persist diseas conserv surgic procedur 